EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure

Mihai Cristian Marinescu iD, Violeta Diana Oprea iD, Sorina Nicoleta Munteanu, Aurel Nechita, Dana Tutunaru, Luiza Camelia Nechita, Aurelia Romila

Diagnostics · 10.04.2024 · 14 (8) · 795

DOI: 10.3390/diagnostics14080795 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 10.04.2024. Verfasst von Mihai Cristian Marinescu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, "Dunărea de Jos" University in Galați, 800216 Galați, Romania. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Dunarea de Jos” University of Galati, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure is a global major healthcare problem with millions of hospitalizations annually and with a very high mortality. There is an increased interest in finding new and reliable biomarkers for the diagnostic, prognostic and therapeutic guidance of patients hospitalized for acute heart failure; Our review aims to summarize in an easy-to-follow flow recent relevant research evaluating the possible use and the clinical value of measuring CA 125 serum levels in acute HF.

Methods

A thorough search in the main international databases identified a relevant pool of 170 articles, providing recently published data for this narrative review that used PRISMA guidelines.

Results

There are data to sustain the role of carbohydrate antigen 125 (CA 125), a worldwide used marker of ovarian cancer, in patients with heart failure. Several studies have shown links between CA 125 levels and congestion seen in acute heart failure, high mortality and readmission rates at 6 months follow-up after discharge from acute heart failure and also a role of CA 125 in the guidance of heart failure therapy. There are also clinical trials that showed that several particularities of CA 125 make it even better than N-terminal pro b-type natriuretic peptide (NT-pro BNP)—a classical and more utilized marker of heart failure) in several scenarios of acute heart failure.

Conclusions

Although the mechanism behind the upregulation of serum CA 125 in patients with congestive HF has not been confirmed nor fully understood.

Schlagwörter

Stichwörter der Autor:innen

CA 125N-terminal pro b-type natriuretic peptideNT-pro BNPacute heart failurecarbohydrate antigen 125congestive heart failure

Autor:innen und Institutionen

  • Faculty of Medicine and Pharmacy, "Dunărea de Jos" University in Galați, 800216 Galați, Romania.
  • St. Apostle Andrei Clinical Emergency County Hospital, 800578 Galați, Romania.
  • St. Ioan Emergency Clinical Hospital for Children, 800487 Galați, Romania.

ORCID-Profile: Mihai Cristian Marinescu, Violeta Diana Oprea

Förderung

  • “Dunarea de Jos” University of Galati, Romania

Zitieren

APA

Marinescu, M. C., Oprea, V. D., Munteanu, S. N., Nechita, A., Tutunaru, D., Nechita, L. C., & Romila, A. (2024). Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure. Diagnostics, 14(8), 795. https://doi.org/10.3390/diagnostics14080795

Vancouver

Marinescu MC, Oprea VD, Munteanu SN, Nechita A, Tutunaru D, Nechita LC, et al. Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure. Diagnostics. 2024;14(8):795. doi:10.3390/diagnostics14080795

BibTeX
@article{Marinescu2024,
  author = {Marinescu, Mihai Cristian and Oprea, Violeta Diana and Munteanu, Sorina Nicoleta and Nechita, Aurel and Tutunaru, Dana and Nechita, Luiza Camelia and Romila, Aurelia},
  title = {Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {795},
  doi = {10.3390/diagnostics14080795}
}
Kostenlos starten →